Biodexa Pharmaceuticals Plc
BDRX
$7.45
-$0.06-0.77%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -8.06M | -7.61M | -7.31M | -7.94M | -8.59M |
| Total Depreciation and Amortization | 331.50K | 323.80K | 321.80K | 332.60K | 343.80K |
| Total Amortization of Deferred Charges | 2.60K | 2.60K | 2.60K | 3.20K | 3.80K |
| Total Other Non-Cash Items | -2.43M | -3.18M | -3.92M | -2.03M | -112.30K |
| Change in Net Operating Assets | -3.75M | -4.27M | -4.80M | -3.12M | -1.42M |
| Cash from Operations | -13.91M | -14.74M | -15.70M | -12.76M | -9.77M |
| Capital Expenditure | -14.30K | -13.00K | -11.70K | -19.60K | -27.60K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 2.50K | 5.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -224.20K | -474.70K | -740.60K | -1.01M | -1.29M |
| Cash from Investing | -238.50K | -487.70K | -752.30K | -1.03M | -1.31M |
| Total Debt Issued | 431.00K | 431.00K | 431.00K | 215.50K | -- |
| Total Debt Repaid | -324.00K | -255.00K | -186.00K | -186.00K | -186.00K |
| Issuance of Common Stock | 10.58M | 9.82M | 9.07M | 9.77M | 10.47M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -763.00K | -758.00K | -753.00K | -1.21M | -1.66M |
| Cash from Financing | 12.85M | 11.76M | 10.93M | 10.89M | 10.86M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.30M | -3.46M | -5.53M | -2.90M | -225.50K |